Keynote speakers

Humphrey Cadoux-Hudson Humphrey Cadoux-Hudson,
Managing director nuclear new build, EDF Energy

Humphrey studied engineering and management at Manchester University and worked at KPMG before joining Seeboard in 1991.

He was appointed executive director in May 2000 with responsibility for Seeboard's non-regulated businesses and group strategy. Following Seeboard’s acquisition by EDF Group in 2002, he was appointed strategy and development director with responsibility for the operations and development of non-regulated networks businesses.

Following the change to EDF Energy, he was appointed chief financial officer and became a member of the Board. His responsibilities included finance functions, procurement, property, legal and information technology.

In January 2009 he was appointed managing director nuclear new build following EDF Energy’s integration with British Energy. He is responsible for the delivery of EDF Energy’s plans to build four new EPR nuclear reactors in the UK.


Paul_Howarth Paul Howarth
Managing director, National Nuclear Laboratory

Paul Howarth has led NNL through its transformation to a government owned government operated organisation, key to the UK’s nuclear energy programmes.

He is an executive director of Battelle Energy UK and a visiting professor at the University of Manchester, where in 2006, he co-founded the Dalton Nuclear Institute. In December 2014 Paul joined the NPL Board as a non-executive director.

Paul held various senior roles at BNFL, worked on the Japanese nuclear programme and on industrial applications of plasma technology. He sits on various R&D committees and on the Board of the Association of Independent Research & Technology Organisations (AIRTO).

Paul holds degrees in physics, astrophysics and business administration. He gained his PhD under Culham’s fusion programme, is a Fellow of the Institute of Physics and the Nuclear Institute and was elected to the Royal Academy of Engineering in 2014.


tom-greatrex-photograph Tom Greatrex
Chief executive, Nuclear Industry Association

Tom became chief executive of the NIA on 1 February 2016. Formerly MP for Rutherglen and Hamilton West, Tom was shadow energy minister from 2011 – 2015 and the opposition’s lead spokesman on nuclear energy, electricity market reform, smart grid and metering, carbon capture and storage, interconnection and both onshore and offshore oil and gas.

Leading the scrutiny of the Energy Act and the Infrastructure Act in the last Parliament, he secured a number of amendments to the proposed legislation. He also served as a member of the Energy Select Committee from 2010 and from 2007-2010 was a policy adviser in the Scotland Office, including on energy.

Since 2015, he has been an independent policy analyst working in the energy sector for a range of clients, a frequent media commentator on energy issues, and a regular columnist for Utility Week. In a varied prior career, he was director of corporate affairs for the NHS in Scotland, a chief officer in local government and a GMB trade union official in England.


melanie-brownridge-photograph Melanie Brownridge
Head of technology, NDA

Melanie joined the NDA in 2005 and is currently Head of Technology. She is responsible for the development and implementation of NDA’s R&D strategy across the NDA’s decommissioning portfolio. She has worked in the nuclear industry for 19 years.

She is a Non-Executive Director of Radioactive Waste Management Ltd, a wholly-owned subsidiary of NDA, and has held this post since it’s formation in April 2014.

Melanie previously worked in BNFL in Research and Technology (now National Nuclear Laboratory) in various roles from plant support to programme manager for legacy waste characterisation.

Melanie is a Fellow of the Royal Society of Chemistry and a Visiting Professor at the University of Leeds.


Gerry Thomas Gerry Thomas
Professor of molecular pathology, Imperial College London

Along with being professor of molecular pathology, Gerry is also director of the newly established West London Genome Medicine Centre, principal scientist for the Wales Cancer Bank and director of both Imperial College Healthcare Tissue Bank and the Chernobyl Tissue Bank (CTB). She is committed to developing infrastructures for molecular pathology research and diagnosis, both for use by her own research group but also by others. She strongly believes that public involvement and information is a key part of academic research, and is actively involved in the public communication of research, particularly with respect to radiation protection and biobanking. 

She has published extensively on the molecular pathology of thyroid cancer, and is an author of a number of reviews of the health effects of radiation exposure following nuclear accidents.  She was invited to speak at the Expert Meeting on the Health Effects of Radiation held in Fukushima in September 2011, and was invited by the UK chief scientist to join the UK-Japan dialogue on nuclear energy in 2012 and lead the public communication workstream.

  

More keynotes to be announced, register your interest here to be kept up to date.

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).